. (2003). Cost and effectiveness of brinzolamide versus dorzolamide in current practice: an analysis based on the UK-GPRD database. J Med Econ.
A. Lafuma
First name
A.
Last name
Lafuma
. (2007). Costs and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma: analysis conducted on the United Kingdom General Practitioner Research Database. Curr Med Res Opin. http://doi.org/10.1185/030079907x242836
. (2008). Costs and persistence of alpha-2 adrenergic agonists versus carbonic anhydrase inhibitors, both associated with prostaglandin analogues, for glaucoma as recorded by The United Kingdom General Practitioner Research Database. Clin Ophthalmol.
. (2008). Costs and persistence of brimonidine versus brinzolamide in everyday glaucoma care: an analysis conducted on the UK General Practitioner Research Database. J Med Econ. http://doi.org/10.3111/13696990802211107
. (2008). Costs and persistence of carbonic anhydrase inhibitor versus alpha-2 agonists, associated with beta-blockers, in glaucoma and ocular hypertension: an analysis of the UK-GPRD database. Curr Med Res Opin. http://doi.org/10.1185/030079908x292038
. (2009). Cost effectiveness of travoprost versus a fixed combination of latanoprost/timolol in patients with ocular hypertension or glaucoma: analysis based on the UK general practitioner research database. Clin Drug Investig. http://doi.org/10.2165/0044011-200929020-00005
. (2011). Treatment persistence and cost-effectiveness of latanoprost/latanoprost-timolol, bimatoprost/bimatoprost-timolol, and travoprost/travoprost-timolol in glaucoma: an analysis based on the United Kingdom general practitioner research database. Clin Ophthalmol. http://doi.org/10.2147/opth.s16888